1. ”Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme”
by Michele Stella, Luca Falzone, Angela Caponnetto, Giuseppe Gattuso, Cristina Barbagallo, Rosalia Battaglia, Federica Mirabella, Giuseppe Broggi, Roberto Altieri, Francesco Certo et al.
Pharmaceuticals 2021, 14(7), 618; https://doi.org/10.3390/ph14070618
Available online: https://www.mdpi.com/1424-8247/14/7/618
2. “Lung Fibrosis after COVID-19: Treatment Prospects”
by Evgeny Bazdyrev, Polina Rusina, Maria Panova, Fedor Novikov, Ivan Grishagin and Vladimir Nebolsin
Pharmaceuticals 2021, 14(8), 807; https://doi.org/10.3390/ph14080807
Available online: https://www.mdpi.com/1424-8247/14/8/807
3. “Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences”
by Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, Anna Pintaudi, Marco Baldini, Stefano Aringhieri, Irene Fasciani, Paolo Annibale, Roberto Maggio and Marco Scarselli
Pharmaceuticals 2021, 14(3), 238; https://doi.org/10.3390/ph14030238
Available online: https://www.mdpi.com/1424-8247/14/3/238
4. “Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats”
by Anna-Maria Costa, Fabiana Russo, Lara Senn, Davide Ibatici, Giuseppe Cannazza and Giuseppe Biagini
Pharmaceuticals 2022, 15(5), 495; https://doi.org/10.3390/ph15050495
Available online：https://www.mdpi.com/1424-8247/15/5/495
5. “N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review”
by Marta Guerini, Giorgia Condrò, Valeria Friuli, Lauretta Maggi and Paola Perugini
Pharmaceuticals 2022, 15(2), 217; https://doi.org/10.3390/ph15020217
Available online: https://www.mdpi.com/1424-8247/15/2/217
